Anticorps Monoclonal anti-PD-1/CD279

PD-1/CD279 Monoclonal Antibody for FC, IF

Hôte / Isotype

Mouse / IgG2b

Réactivité testée

Humain, rat, souris

Applications

IF, FC

Conjugaison

CoraLite® Plus 647 Fluorescent Dye

Publications

2

CloneNo.

4H4D1

N° de cat : CL647-66220

Synonymes

CD279, hPD 1, hPD l, PD1, PD-1/CD279, PDCD1, programmed cell death 1, Protein PD 1, SLEB2

---

Galerie de données de validation

• 

  IF Staining of human tonsillitis using CL647-66220

  Immunofluorescent analysis of (4% PFA) fixed human tonsillitis tissue using CoraLite® Plus 647 PD-1/CD279 antibody (CL647-66220, Clone: 4H4D1 ) at dilution of 1:100.

• 

  IF Staining of human tonsillitis using CL647-66220

  Immunofluorescent analysis of (4% PFA) fixed human tonsillitis tissue using CoraLite® Plus 647 PD-1/CD279 antibody (CL647-66220, Clone: 4H4D1 ) at dilution of 1:100.

• 

  IF Staining of human tonsillitis using CL647-66220

  Immunofluorescent analysis of (4% PFA) fixed human tonsillitis tissue using CoraLite® Plus 647 PD-1/CD279 antibody (CL647-66220, Clone: 4H4D1 ) at dilution of 1:200, CoraLite®594 CD11c/Integrin Alpha X antibody (CL594-60258, Clone: 2F1C10, red), CoraLite®488 CD8 antibody (CL488-66868, Clone: 1G2B10, green).

• 

  FC experiment of PBMC using CL647-66220

  1X10^6 PHA-stimulated (5 μg/mL, overnight) human peripheral blood mononuclear cells (PBMCs) were surface stained with 0.20 ug CoraLite647-conjugated Anti-Human PD-1/CD279 (CL647-66220, clone: 4H4D1) and 0.20 ug FITC-Anti-Human CD3 (FITC-65151, clone UCHT1). Cells were not fixed.

• 

  FC experiment of PBMC using CL647-66220

  1X10^6 human peripheral blood mononuclear cells (PBMCs) were surface stained with 0.20 ug CoraLite647-conjugated Anti-Human PD-1/CD279 (CL647-66220, clone: 4H4D1) and 0.20 ug FITC-Anti-Human CD3 (FITC-65151, clone UCHT1). Cells were not fixed.

---

Applications testées

• Résultats positifs en IF: tissu d'amygdalite humain,
• Résultats positifs en cytométrie: cellules PBMC

Dilution recommandée

• Immunofluorescence (IF): IF : 1:50-1:500
• Flow Cytometry (FC): FC : 0.20 ug per 10^6 cells in a 100 µl suspension

It is recommended that this reagent should be titrated in each testing system to obtain optimal results.

Sample-dependent, check data in validation data gallery

Applications publiées

• IF: See 1 publications below
• FC: See 1 publications below

Informations sur le produit

CL647-66220 cible PD-1/CD279 dans les applications de IF, FC et montre une réactivité avec des échantillons Humain, rat, souris

• Réactivité: Humain, rat, souris
• Réactivité citée: rat, souris
• Hôte / Isotype: Mouse / IgG2b
• Clonalité: Monoclonal
• Type: Anticorps
• Immunogène: PD-1/CD279 Protéine recombinante Ag12470
• Nom complet: programmed cell death 1
• Masse moléculaire calculée: 288 aa, 32 kDa
• Numéro d’acquisition GenBank: BC074740
• Symbole du gène: PDCD1
• Identification du gène (NCBI): 5133
• Conjugaison: CoraLite® Plus 647 Fluorescent Dye
• Excitation/Emission maxima wavelengths: 654 nm / 674 nm
• Forme: Liquide
• Méthode de purification: Purification par protéine A
• Tampon de stockage: PBS avec glycérol à 50 %, Proclin300 à 0,05 % et BSA à 0,5 %, pH 7,3.
• Conditions de stockage: Stocker à -20 °C. Éviter toute exposition à la lumière. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20^oC Les 20ul contiennent 0,1% de BSA.

Informations générales

Programmed cell death 1 (PD-1, also known as CD279) is an immunoinhibitory receptor that belongs to the CD28/CTLA-4 subfamily of the Ig superfamily. It is a 288 amino acid (aa) type I transmembrane protein composed of one Ig superfamily domain, a stalk, a transmembrane domain, and an intracellular domain containing an immunoreceptor tyrosine-based inhibitory motif (ITIM) as well as an immunoreceptor tyrosine-based switch motif (ITSM) (PMID: 18173375). PD-1 is expressed during thymic development and is induced in a variety of hematopoietic cells in the periphery by antigen receptor signaling and cytokines (PMID: 20636820). Engagement of PD-1 by its ligands PD-L1 or PD-L2 transduces a signal that inhibits T-cell proliferation, cytokine production, and cytolytic function (PMID: 19426218). It is critical for the regulation of T cell function during immunity and tolerance. Blockade of PD-1 can overcome immune resistance and also has been shown to have antitumor activity (PMID: 22658127; 23169436). The calculated molecular weight of PD-1 is 32 kDa. It has been reported that PD-1 is heavily glycosylated and migrates with an apparent molecular mass of 47-55 kDa on SDS-PAGE (PMID: 8671665; 17640856; 17003438).

Publications

Species	Application	Title
mouse	IF	Clin Cancer Res; 18F-FMISO PET Imaging Identifies Hypoxia and Immunosuppressive Tumor Microenvironments and Guides Targeted Evofosfamide Therapy in Tumors Refractory to PD-1 and CTLA-4 Inhibition.; Authors - Kirsten M Reeves
rat	FC	Transplantation; Activation of the Aryl Hydrocarbon Receptor Ameliorates Acute Rejection of Rat Liver Transplantation by Regulating Treg Proliferation and PD-1 Expression.; Authors - Wanyue Cao